510(k) K260528— OncoStudio

Substantially Equivalent

Oncosoft. Inc.,

Clearance details

Applicant: Oncosoft. Inc.,
Product code: Code QKB
Advisory panel: Radiology
Date received: 2026-02-17
Decision date: 2026-07-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Seoul, KR

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.